We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.45B
AUM Growth
+$336M
Cap. Flow
+$603M
Cap. Flow %
41.48%
Top 10 Hldgs %
67.23%
Holding
768
New
375
Increased
70
Reduced
59
Closed
238

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$151M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$48.3M
3
ITOS
iTeos Therapeutics
ITOS
+$21.3M
4
QNGY
Quanergy Systems, Inc.
QNGY
+$11.5M
5
FULC icon
Fulcrum Therapeutics
FULC
+$10.9M

Top Sells

Rank Stock Value
1
SMH icon
VanEck Semiconductor ETF
SMH
+$30.8M
2
DIS icon
Walt Disney
DIS
+$23.1M
3
NGHC
National General Holdings Corp
NGHC
+$20.7M
4
STLA icon
Stellantis
STLA
+$19.7M
5
SVOKU
Seven Oaks Acquisition Corp. Unit
SVOKU
+$16M

Sector Composition

Rank Sector Weight
1 Healthcare 11.15%
2 Financials 9.75%
3 Technology 2.87%
4 Industrials 2.67%
5 Consumer Discretionary 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KPLT icon
501
CALL
Katapult Holdings
KPLT
$39.8M
$7K ﹤0.01%
+3,688
New +$1.42M
NKTR icon
502
CALL
Nektar Therapeutics
NKTR
$2.55B
$7K ﹤0.01%
333
-1,227
-79% -$382K
NKTR icon
503
PUT
Nektar Therapeutics
NKTR
$2.55B
$7K ﹤0.01%
333
-1,580
-83% -$492K
VTRS icon
504
PUT
Viatris
VTRS
$18.7B
$7K ﹤0.01%
+6,100
New +$99.4K
FPRX
505
CALL
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$7K ﹤0.01%
+90,200
New +$2.25M
VYX icon
506
CALL
NCR Voyix
VYX
$1.11B
$6K ﹤0.01%
+6,520
New +$143K
PMGMW
507
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$6K ﹤0.01%
+10,000
New +$7.36K
RDUS
508
CALL
DELISTED
Radius Health, Inc.
RDUS
$6K ﹤0.01%
15,000
– –
KSU
509
PUT
DELISTED
Kansas City Southern
KSU
$6K ﹤0.01%
+4,900
New +$1.07M
GUT.RT
510
DELISTED
Gabelli Utility Trust (The) Rights (expiring April 14, 2021)
GUT.RT
$6K ﹤0.01%
+50,000
New +$7.33K
WBD icon
511
CALL
Warner Bros
WBD
$67.9B
$5K ﹤0.01%
+37,800
New +$1.89M
VHAQ.RT
512
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$5K ﹤0.01%
+25,000
New +$5.83K
EDTXW
513
DELISTED
EdtechX Holdings Acquisition Corp. II Warrant
EDTXW
$5K ﹤0.01%
+10,000
New +$8.44K
COF icon
514
PUT
Capital One
COF
$134B
$4K ﹤0.01%
+600
New +$70.7K
QSI icon
515
CALL
Quantum-Si Incorporated
QSI
$179M
$4K ﹤0.01%
+71,100
New +$859K
SKIL icon
516
CALL
Skillsoft
SKIL
$84.4M
$4K ﹤0.01%
+2,600
New +$532K
SNAX
517
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$4K ﹤0.01%
27,331
– –
RDUS
518
DELISTED
Radius Health, Inc.
RDUS
$4K ﹤0.01%
+174
New +$3.67K
PS
519
PUT
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$4K ﹤0.01%
8,000
-8,500
-52% -$182K
AUPH icon
520
CALL
Aurinia Pharmaceuticals
AUPH
$2.04B
$3K ﹤0.01%
25,000
-9,800
-28% -$142K
SIOX
521
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$3K ﹤0.01%
22,500
+3,500
+18% +$9.9K
ACAD icon
522
CALL
Acadia Pharmaceuticals
ACAD
$5.07B
$2K ﹤0.01%
+2,300
New +$101K
HBI
523
DELISTED
Hanesbrands
HBI
$2K ﹤0.01%
+101
New +$1.79K
HBI
524
PUT
DELISTED
Hanesbrands
HBI
$2K ﹤0.01%
+37,500
New +$664K
MAT icon
525
PUT
Mattel
MAT
$4.29B
$2K ﹤0.01%
+20,500
New +$396K
19 20
21
22 23

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2021 Portfolio in Review

As of Q1 2021, Cowen and Company held 768 positions worth $1.45B, up 30% from $1.12B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $603M of net new capital in Q1 2021, opening 375 new positions and adding to 70 existing holdings. Its largest new stake was iTeos Therapeutics: 588,238 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 4.9% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Freeport-McMoran, an estimated $5.42M trimmed.

  • Cowen and Company's largest Q1 2021 buy was iTeos Therapeutics: 588,238 shares worth $20.1M.
  • Cowen and Company added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2021, an estimated $151M increase.
  • Cowen and Company's biggest Q1 2021 reduction was Freeport-McMoran, cutting an estimated $5.42M.
  • Cowen and Company fully exited VanEck Semiconductor ETF in Q1 2021, selling an estimated $30.8M.
  • Cowen and Company's ten largest holdings make up 67% of its $1.45B portfolio in Q1 2021.
  • Cowen and Company opened 375 new positions and closed 238 in Q1 2021.
  • Cowen and Company's portfolio value rose 30% quarter-over-quarter to $1.45B.

Based on Cowen and Company's 13F filing for Q1 2021, filed 4 May 2021.